CLS Holdings USA Inc (CLSH)
0.054
0.00 (0.00%)
USD |
OTCM |
May 17, 15:59
CLS Holdings USA Revenue (Quarterly): 4.926M for Feb. 29, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 4.926M |
| November 30, 2023 | 5.197M |
| August 31, 2023 | 5.114M |
| May 31, 2023 | 5.577M |
| February 28, 2023 | 5.437M |
| November 30, 2022 | 6.074M |
| August 31, 2022 | 6.045M |
| May 31, 2022 | 6.160M |
| February 28, 2022 | 5.588M |
| November 30, 2021 | 5.414M |
| August 31, 2021 | 5.501M |
| May 31, 2021 | 6.059M |
| Date | Value |
|---|---|
| February 28, 2021 | 4.544M |
| November 30, 2020 | 4.908M |
| August 31, 2020 | 3.781M |
| May 31, 2020 | 2.778M |
| February 29, 2020 | 3.224M |
| November 30, 2019 | 3.056M |
| August 31, 2019 | 2.859M |
| May 31, 2019 | 2.93M |
| February 28, 2019 | 2.373M |
| November 30, 2018 | 1.977M |
| August 31, 2018 | 1.179M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.778M
Minimum
May 2020
6.160M
Maximum
May 2022
4.759M
Average
5.156M
Median
Revenue (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.631M |
| Palatin Technologies Inc | 2.034M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.369M |
| Total Expenses (Quarterly) | 5.365M |
| EPS Diluted (Quarterly) | -0.04 |
| Enterprise Value | 12.64M |
| Gross Profit Margin (Quarterly) | 43.17% |
| Profit Margin (Quarterly) | -88.69% |
| Earnings Yield | -203.7% |
| Normalized Earnings Yield | -126.86 |